These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12170 related articles for article (PubMed ID: 11205230)

  • 1. Hereditary common cancers: molecular and clinical genetics.
    Russo A; Zanna I; Tubiolo C; Migliavacca M; Bazan V; Latteri MA; Tomasino RM; Gebbia N
    Anticancer Res; 2000; 20(6C):4841-51. PubMed ID: 11205230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited predisposition to cancer: a historical overview.
    Lynch HT; Shaw TG; Lynch JF
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary ovarian cancer.
    Prat J; Ribé A; Gallardo A
    Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-susceptibility markers.
    Bellet D
    J Natl Cancer Inst Monogr; 1992; (12):115-21. PubMed ID: 1616794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary neoplastic diseases (genetic predisposition and cancer syndromes)].
    Oláh E
    Orv Hetil; 1999 Feb; 140(9):451-66. PubMed ID: 10204401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic predisposition and ovarian cancer].
    Coupier I; Gauthier-Villars M; This P; Stoppa-Lyonnet D
    Rev Prat; 2004 Oct; 54(16):1757-62. PubMed ID: 15630879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer genetics in primary care.
    Culler D; Grimes SJ; Acheson LS; Wiesner GL
    Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
    Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
    J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited genetic susceptibility to breast cancer.
    Chang-Claude J
    IARC Sci Publ; 2001; 154():177-90. PubMed ID: 11220657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inherited breast and ovarian cancers].
    Gerdes AM; Ejlertsen B
    Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 609.